Transgene
About:
Transgene is a biotechnology company that designs and develops innovative immunotherapies.
Website: http://www.transgene.fr
Twitter/X: TransgeneSA
Top Investors: Natixis
Description:
Transgene is an integrated biopharmaceutical company that designs and develops cutting-edge immunotherapeutic products to treat cancers and chronic infectious diseases. Their expertise covers all stages of product development, from research to the manufacture of clinical batches, and the conducting of clinical trials.
Total Funding Amount:
82.5M EUR
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
Illkirch-graffenstaden, Alsace, France
Founded Date:
1979-01-01
Contact Email:
communication(AT)transgene.fr
Founders:
Pierre Chambon
Number of Employees:
501-1000
Last Funding Date:
2023-07-17
IPO Status:
Public
Industries:
© 2025 bioDAO.ai